肺炎克雷伯菌菌毛亚单位用于疫苗开发的计算机模拟与实验分析
本研究通过计算机模拟分析肺炎克雷伯菌1型和3型菌毛亚单位(FimA、FimH、MrkA、MrkD)的免疫潜力,并将FimA和MrkA基因克隆表达、纯化后以铝佐剂皮下免疫小鼠。结果显示重组FimA和MrkA可诱导特异性IgG产生;MrkA免疫组在攻击高毒力菌株后生存时间略有增加,但所有小鼠均在感染5天内死亡。
要点
- 计算机模拟显示FimA、FimH、MrkA、MrkD均含预测的B细胞和T细胞表位。
- 重组FimA和MrkA以铝佐剂皮下免疫小鼠可诱导特异性IgG产生。
- MrkA免疫组攻击后生存时间略有增加,但所有小鼠5天内死亡。
核心结论
- 计算机模拟分析提示肺炎克雷伯菌菌毛组分是有前景的疫苗候选,但针对荚膜增加的高毒力菌株的保护可能需要额外抗原。
研究设计与样本
- 对1型菌毛(FimA和FimH)和3型菌毛(MrkA和MrkD)组分进行计算机模拟分析。
- 将编码菌毛亚单位FimA和MrkA的基因克隆入原核载体系统,在大肠杆菌中表达并经Ni2+亲和色谱纯化。
- 以铝佐剂皮下免疫小鼠,检测特异性IgG产生;并测试MrkA免疫对高毒力肺炎克雷伯菌株攻击的保护潜力。
主要发现
- 计算机模拟显示所有四种蛋白均含预测可结合至肽结合槽的B细胞和T细胞表位。
- 7等位基因预测模型评估显示部分表位有潜力在不同II类MHC等位基因间呈递。
- 重组FimA和MrkA以铝佐剂皮下免疫小鼠诱导了特异性IgG产生。
- MrkA免疫组在攻击高毒力菌株后生存时间略有增加,但所有小鼠均在感染5天内死亡。
局限性
- MrkA免疫组虽生存时间略有增加,但所有小鼠均在感染5天内死亡。
- 针对荚膜增加的高毒力菌株的保护可能需要额外抗原。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Klebsiella pneumoniae infections pose a great burden worldwide, causing high morbidity and mortality. New therapeutic/prophylactic strategies are urgently needed to overcome antibiotic resistance and reduce the health and economic impacts of diseases caused by this pathogen. Fimbriae are important virulence factors involved in biofilm formation and adhesion to host cells. Their exposed location and conservation among clinical isolates make them interesting candidates for inclusion in protein-based vaccines. Therefore, the present work investigated the immunological potential of K. pneumoniae fimbriae subunits as vaccine candidates. In-silico analysis of the type 1 (FimA and FimH) and type 3 (MrkA and MrkD) fimbrial components showed that all four proteins contain B- and T- cell epitopes predicted to bind into the peptide binding cleft. Additionally, a 7-allele prediction model was used to assess the binding and presentation of these epitopes, with some showing potential for presentation across different class II MHC alleles. The genes encoding fimbriae subunits FimA and MrkA were cloned in prokaryotic vector systems, expressed in E. coli and purified by Ni2+ affinity chromatography. Subcutaneous immunization of mice with recombinant FimA and MrkA using Alum as adjuvant induced specific IgG production. The protective potential of MrkA immunization was tested against challenge with a hypervirulent K. pneumoniae strain; although a modest increase in survival time was observed in the immunized group, all mice died within 5 days of infection. Overall, although the in-silico analysis suggests that K. pneumoniae fimbriae components promising vaccine candidates, protection against highly virulent strains with increased capsule may require additional antigens.
引用
- Assoni L, Valim V, Couto AJM, et al. In-silico and experimental analysis of Klebsiella pneumoniae fimbriae subunits for vaccine development. Vaccine. 2025. PMID: 40203594. doi:10.1016/j.vaccine.2025.127075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。